Al-Dawaa Medical Services Company (TADAWUL:4163) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The revenue forecast for this year has experienced a facelift, with the analysts now much more optimistic on its sales pipeline. Investor sentiment seems to be improving too, with the share price up 4.7% to ر.س79.90 over the past 7 days. It will be interesting to see if this latest upgrade is enough to kickstart further buying interest in the stock.
Following the upgrade, the current consensus from Al-Dawaa Medical Services' five analysts is for revenues of ر.س7.7b in 2025 which - if met - would reflect a decent 20% increase on its sales over the past 12 months. Prior to the latest estimates, the analysts were forecasting revenues of ر.س7.0b in 2025. It looks like there's been a clear increase in optimism around Al-Dawaa Medical Services, given the decent improvement in revenue forecasts.
View our latest analysis for Al-Dawaa Medical Services
One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. It's clear from the latest estimates that Al-Dawaa Medical Services' rate of growth is expected to accelerate meaningfully, with the forecast 20% annualised revenue growth to the end of 2025 noticeably faster than its historical growth of 7.4% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 7.4% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Al-Dawaa Medical Services is expected to grow much faster than its industry.
The highlight for us was that analysts increased their revenue forecasts for Al-Dawaa Medical Services this year. Analysts also expect revenues to grow faster than the wider market. Seeing the dramatic upgrade to this year's forecasts, it might be time to take another look at Al-Dawaa Medical Services.
Want to learn more? We have analyst estimates for Al-Dawaa Medical Services going out to 2027, and you can see them free on our platform here.
Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are upgrading their estimates. So you may also wish to search this free list of stocks with high insider ownership.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.